HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

The study will evaluate the safety and effectiveness of a lower than standard dose of radiation for definitive or adjuvant treatment of head and neck squamous cell carcinomas.

Trial Details

NCT ID
NCT05962242
Phase
PHASE2
Sponsor
University of Virginia
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Radiation Therapy
Locations (sample)
  • Miami, Florida, United States|25.77427,-80.19366
  • Charlottesville, Virginia, United States|38.02931,-78.47668
  • Norfolk, Virginia, United States|36.84681,-76.28522
  • Richmond, Virginia, United States|37.55376,-77.46026
  • Richmond, Virginia, United States|37.55376,-77.46026

Key Eligibility Criteria

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, ≥ 18 years of age
  • Pathologically proven diagnosis of squamous cell carcinoma of the oropharynx of any AJCC 8th edition stage.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →